DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CSL-360
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Interleukin-3 receptor subunit alpha inhibitor
CSL-360
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FILANESIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Leukemia, Plasma Cell; Myelodysplastic Syndromes; Neoplasms; Multiple Myeloma
Kinesin-like protein 1 inhibitor
FILANESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
8A49OSO368
Molecule Type:
Small molecule
Molecular Formula:
C20H22F2N4O2S
Molecular Weight:
420.49
AlogP:
3.88
PSA:
71.16
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MEDI-639
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MEDI-639
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZIRALIMUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Basigin inhibitor
ZIRALIMUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APOCYNIN
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cardiovascular Diseases; Pulmonary Disease, Chronic Obstructive
Unknown
APOCYNIN
×
Maximum Phase:
1
First Approval:
None
UNII:
B6J7B9UDTR
Molecule Type:
Small molecule
Molecular Formula:
C9H10O3
Molecular Weight:
166.18
AlogP:
1.6
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CNTO-5825
1
Antibody
Investigational
Unknown
Unknown
Unknown
Interleukin-13 inhibitor
CNTO-5825
×
Maximum Phase:
1
First Approval:
None
UNII:
JYB0ILB7HU
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PBF-509
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Parkinson Disease
Adenosine A2a receptor antagonist
PBF-509
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MDX-1303
1
Antibody
Investigational
Unknown
Unknown
Anthrax; Hypersensitivity
Protective antigen inhibitor
MDX-1303
×
Maximum Phase:
1
First Approval:
None
UNII:
7D0R3114J3
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CLN-081
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
CLN-081
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H20N6O
Molecular Weight:
396.45
AlogP:
3.32
PSA:
98.72
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CXD-101
1
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms
Unknown
CXD-101
×
Maximum Phase:
1
First Approval:
None
UNII:
5TNV87ICD2
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O
Molecular Weight:
403.53
AlogP:
3.94
PSA:
76.18
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CDX-014
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Renal Cell
Unknown
CDX-014
×
Maximum Phase:
1
First Approval:
None
UNII:
GJV1PP34M2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
IGN-002
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Unknown
IGN-002
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7602
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
RG-7602
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIGILANOL TIGLATE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
TIGILANOL TIGLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
R1ZJT87990
Molecule Type:
Small molecule
Molecular Formula:
C30H42O10
Molecular Weight:
562.66
AlogP:
1.23
PSA:
163.12
HBD:
4.0
HBA:
#RotB:
6.0
Source:
ENAPOTAMAB VEDOTIN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Tubulin inhibitor
ENAPOTAMAB VEDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
43HH4XYH2N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MASLIMOMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
T-cell receptor inhibitor
MASLIMOMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBACYCLIC PHOSPHATIDIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Unknown
CARBACYCLIC PHOSPHATIDIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
OXV962AR86
Molecule Type:
Small molecule
Molecular Formula:
C22H41O5P
Molecular Weight:
416.54
AlogP:
6.4
PSA:
72.83
HBD:
1.0
HBA:
#RotB:
17.0
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PDT
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PDT
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
18F-FAZA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
18F-FAZA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
TEGAVIVINT
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Fibromatosis, Aggressive; Leukemia
Unknown
TEGAVIVINT
×
Maximum Phase:
1
First Approval:
None
UNII:
18AP231HUP
Molecule Type:
Small molecule
Molecular Formula:
C28H36N4O6S2
Molecular Weight:
588.75
AlogP:
3.79
PSA:
139.94
HBD:
2.0
HBA:
#RotB:
4.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PEGULICIANINE ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PEGULICIANINE ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
F3F6208UMT
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-GALACTOSE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-GALACTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
CEVOSTAMAB
1
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
CEVOSTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYTOCHLOR
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Head and Neck Neoplasms
Unknown
CYTOCHLOR
×
Maximum Phase:
1
First Approval:
None
UNII:
J14D49ZN55
Molecule Type:
Small molecule
Molecular Formula:
C9H12ClN3O4
Molecular Weight:
261.67
AlogP:
-0.88
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEP-5214
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
CEP-5214
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H28N2O3
Molecular Weight:
440.54
AlogP:
4.92
PSA:
63.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SAR441236
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SAR441236
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUMRETUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
LUMRETUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
Y6M3205516
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
92
93
94
95
96
97
98
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA